Physician profile
Peter Wolff
NPI 1447258801
$646.90
in general payments reported to CMS, 2019-2025
9 companies · $23.04 in 2025
The $23.04 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52.71 · 2020: $49.20 · 2021: $136 · 2022: $40.05 · 2023: $330 · 2024: $16.64 · 2025: $23.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $369.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $369.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $227.77 | 2021-2023 | Grafix Xc, Stravix Pl, Grafix Pl |
| W. L. Gore & Associates, INC. | $212.15 | 2023 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Organogenesis INC. | $54.85 | 2020-2022 | |
| Braintree Laboratories, INC. | $36.41 | 2019-2024 | Suflave, Sutab |
| Medela LLC | $34.40 | 2020 | |
| Exact Sciences Corporation | $25.34 | 2023 | Cologuard Collection Kit |
| Integra Lifesciences Corporation | $23.04 | 2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Ethicon US, LLC | $22.02 | 2019 | |
| Novartis Pharmaceuticals Corporation | $10.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Wolff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.